Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AFM-30a hydrochloride is a potent and highly selective inhibitor of protein arginine deiminase 2 (PAD2). aFM-30a hydrochloride binds to PAD2 (EC50: 9.5 μM) and also inhibits H3 guanylation (EC50: 0.4 μM). aFM-30a hydrochloride can be used to study certain cancers and various autoimmune diseases such as rheumatoid arthritis (RA), multiple sclerosis, lupus, and ulcerative colitis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,610.00 | |
50 mg | 10-14 weeks | $ 2,690.00 |
Description | AFM-30a hydrochloride is a potent and highly selective inhibitor of protein arginine deiminase 2 (PAD2). aFM-30a hydrochloride binds to PAD2 (EC50: 9.5 μM) and also inhibits H3 guanylation (EC50: 0.4 μM). aFM-30a hydrochloride can be used to study certain cancers and various autoimmune diseases such as rheumatoid arthritis (RA), multiple sclerosis, lupus, and ulcerative colitis. |
Molecular Weight | 502.97 |
Formula | C24H28ClFN6O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AFM-30a hydrochloride inhibitor inhibit